Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.8848
-0.0651 (-6.85%)
Apr 23, 2026, 2:19 PM EDT - Market open
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $10.13 million as of April 23, 2026. Its market cap has increased by 16.04% in one year.
Market Cap
10.13M
Enterprise Value
-4.52M
1-Year Change
16.04%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $10.13M, a decrease of -46.49%. That is a compound annual growth rate of -14.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 10.88M | 82.35% |
| Dec 31, 2025 | 5.97M | -66.64% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reviva Pharmaceuticals Holdings | 11.65M |
| BioLineRx | 11.37M |
| Quoin Pharmaceuticals | 10.89M |
| Kiora Pharmaceuticals | 10.75M |
| Silo Pharma | 10.09M |
| Genprex | 9.86M |
| Evogene | 9.77M |
| Bolt Biotherapeutics | 9.59M |